Am J Transplant, Volume 21, Suppl 3 Archives - Page 111 of 139 - ATC Abstracts

2021 American Transplant Congress
A Question with Multiple Answers: Do Renal Transplant Recipients Require Steroid Maintenance Following Thymoglobulin Induction?
A. Aala, H. Patel, F. Cardarelli
Beth Israel Deaconess Medical Center, Boston, MA
*Purpose: Anti-thymocyte globulin (ATG) has been used with good results in renal transplantation as induction therapy, followed by triple immunosuppression with calcineurin inhibitors, antimetabolites, and…
2021 American Transplant Congress
A Comparison of Belatacept Conversion Regimens from Calcineurin Inhibitor-Based Immunosuppression
E. Huang, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan
Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Outcomes with varying belatacept conversion protocols from calcineurin inhibitor (CNI)-based immunosuppression have been published but no standard protocol has been established. Beginning in 2012,…
2021 American Transplant Congress
Pill Burden in Belatacept versus Tacrolimus-Based Immunosuppression
S. Gattis, L. Lakhani, A. Basu
Emory Healthcare, Atlanta, GA
*Purpose: Medication non-adherence is a major barrier amongst renal transplant recipients, and improvement can be seen after reduction in pill burden. Belatacept versus tacrolimus-based immunosuppression…
2021 American Transplant Congress
The Evaluation of Living-Related Kidney Transplantation Donors in Autosomal-Dominant Polycystic Kidney Disease
T. Kikuchi¹, K. Unagami², Y. Kobari³, T. Yagisawa³, T. Kanzawa³, K. Omoto³, A. Uemura¹, H. Ishida², K. Tanabe³
¹Urology, Kindai University Hospital, Osaka, Japan, ²Organ transplant medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan, ³Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan
*Purpose: Autosomal-dominant polycystic kidney disease (ADPKD) is a progressive hereditary disease caused primarily by gene mutations, leading to multiple kidney cyst occurrence, kidney function deterioration,…
2021 American Transplant Congress
Urine Donor-derived Cell-free is Valuable for Predicting BK Polyomavirus-associated Nephropathy in Kidney Transplant Recipients
G. Huang¹, X. Chen¹, Y. Huang¹, J. Li¹, R. Deng¹, W. Chen², J. Qiu¹, S. Deng¹, G. Chen¹, Q. Fu¹, C. Wu¹, J. Fei¹, L. Liu¹, L. Chen¹, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: Our previous study has proved that urine donor-derived cell-free DNA (dd-cfDNA) can assist in the diagnosis of BK polyomavirus-associated nephropathy (BKPyVAN), but its specificity…
2021 American Transplant Congress
Kidney Transplantation from Offspring to Mothers is Not Associated with Adverse Outcomes
S. Parajuli, N. Garg, A. Djamali, D. Mandelbrot
University of Wisconsin, Madison, WI
*Purpose: Due to concerns of donor-specific alloimmunization during pregnancy, some have suggested avoiding living donor kidney transplants (LDKT) from offspring to biological mothers. Published analyses…
2021 American Transplant Congress
Improving Allograft Survival by Informing Donor Selection in Kidney Transplant Recipients Under 5 Years Old
F. Manca Barayre, L. Greenbaum, R. Garro, P. Winterberg, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: The kidney allocation system aims at allocating high-quality kidneys in pediatric recipients but the KDPI score used to assess the quality of the donors…
2021 American Transplant Congress
The Role of Donor-derived Cell-free DNA Testing in Detecting Subclinical Kidney Allograft Rejection
M. Dasari¹, J. Hendele², L. Sibulesky², N. Leca³
¹Department of Surgery, University of Washington, Seattle, WA, ²Department of Surgery, Division of Transplant, University of Washington, Seattle, WA, ³Department of Nephrology, UW Medicine Kidney and Pancreas Transplantation Program, University of Washington, Seattle, WA
*Purpose: Donor-derived cell-free DNA (dd-cfDNA) testing is an emerging method of non-invasive testing for graft rejection in the field of solid-organ transplantation. We describe how…
2021 American Transplant Congress
Non-HLA Antibodies and Eplet Mismatches in Cases with Histological Picture of Antibody-Mediated Rejection with and without HLA Donor-Specific Antibodies
M. Crespo¹, L. Llinás², D. Redondo², C. Butler³, J. Gimeno⁴, M. Pérez-Sáez², A. Buxeda², C. Arias², M. Folgueiras², S. Sanz², N. Valenzuela³, E. E. Reed³, J. Pascual²
¹Nephrology and Kidney Transplantation, Hospital del Mar, Barcelona, Spain, ²Nephrology, Hospital del Mar, Barcelona, Spain, ³UCLA Immunogenetics Center, UCLA, Los Angeles, CA, ⁴Pathology, Hospital del Mar, Barcelona, Spain
*Purpose: Correlation between antibody-mediated rejection (ABMR) and HLA donor-specific antibodies (DSA) is strong but imperfect in kidney transplant (KT) recipients, raising the possibility of other…
2021 American Transplant Congress
Changes in Glomerular Filtration Rate (delta Egfr) within the First Year Predict Long-Term Outcomes of Renal Grafts
A. M. Thompson, M. Zenati, S. Hariharan, M. Molinari
Starzl Transplant Institute, UPMC, Pittsburgh, PA
*Purpose: The relationship between changes in eGFR (Delta eGFR) during the first year after renal transplantation (RT) and long-term graft survival are poorly understood. We…